{"schema_version":"secwatch.filing_event.v1","accession":"0001588978-24-000018","form_type":"8-K","ticker":"PRCT","cik":"0001588978","company_name":"PROCEPT BioRobotics Corp","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.666305+00:00","generated_at":"2026-05-31T13:49:28.813263+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"PROCEPT BioRobotics Q2 revenue $53.4M (+61% YoY); raises FY2024 revenue and EBITDA guidance","bullets":["Total revenue $53.4M (+61% YoY); U.S. handpiece & consumables $27.3M (+101% YoY).","Net loss $25.6M; Adjusted EBITDA loss $18.0M improved from $19.9M loss in prior period.","Raised FY2024 revenue guidance to ~$217M (from $213.5M); EBITDA loss guidance narrowed to $67.5M from $70M.","Gross margin reached 59% (vs 56% YoY); cash & investments $214.1M; Q2 cash usage $11.5M vs $31.6M in Q1.","Sold 47 U.S. robotic systems in Q2; U.S. install base 400; international revenue $5.7M (+79% YoY)."],"urls":{"canonical":"https://secwatch.observer/filing/0001588978-24-000018","json":"https://secwatch.observer/filing/0001588978-24-000018.json","markdown":"https://secwatch.observer/filing/0001588978-24-000018.md","text":"https://secwatch.observer/filing/0001588978-24-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1588978/000158897824000018/0001588978-24-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1588978/000158897824000018/prct-20240801.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:49:28.813263+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}